THIS CIRCULAR IS IMPORTANT AND REQUIRES YOUR IMMEDIATE ATTENTION
If you are in any doubt as to any aspect of this circular or as to the action to be taken, you should consult a stockbroker or other registered dealer in securities, a bank manager, solicitor, professional accountant or other professional adviser.
If you have sold or transferred all your shares in SciClone Pharmaceuticals (Holdings) Limited, you should at once hand this circular, together with the enclosed form of proxy, to the purchaser or transferee or to the bank, stockbroker or other agent through whom the sale or transfer was effected for transmission to the purchaser or transferee.
Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this circular, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this circular.
SciClone Pharmaceuticals (Holdings) Limited
賽生藥業控股有限公司 *
(Incorporated in the Cayman Islands with limited liability)
(Stock code: 6600)
PROPOSED ELECTION AND RE-ELECTION OF DIRECTORS
AND
PROPOSED GRANTING OF GENERAL MANDATES TO
REPURCHASE SHARES AND TO ISSUE SHARES
AND
NOTICE OF ANNUAL GENERAL MEETING
The notice convening the Annual General Meeting of SciClone Pharmaceuticals (Holdings) Limited to be held at 22/F, Central Plaza, 381 Middle Huaihai Road, Shanghai, PRC on Wednesday, June 16, 2021 at 3:00 p.m. is set out in this circular.
Whether or not you are able to attend the Annual General Meeting, please complete and sign the enclosed form of proxy for use at the Annual General Meeting in accordance with the instructions printed thereon and return it to the Company's branch share registrar in Hong Kong, Tricor Investor Services Limited, at Level 54, Hopewell Centre, 183 Queen's Road East, Hong Kong as soon as possible but in any event not less than 48 hours before the time appointed for the Annual General Meeting (i.e. not later than 3:00 p.m. on Monday, June 14, 2021 (Hong Kong time)) or the adjourned meeting (as the case may be). Completion and return of the form of proxy will not preclude shareholders from attending and voting in person at the Annual General Meeting if they so wish.
This circular together with the form of proxy are also published on the websites of Hong Kong Exchanges and Clearing Limited (http://www.hkexnews.hk) and the Company (http://www.sciclone.com)
References to time and dates in this circular are to Hong Kong time and dates.
* For identification purpose only
May 14, 2021
CONTENTS
Page | ||
Definitions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . | 1 | |
Letter from the Board . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . | 3-6 | |
1. | Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . | 3 |
2. | Proposed Election and Re-election of Directors . . . . . . . . . . . . . . . . . | 4 |
3. Proposed Granting of General Mandate to
Repurchase Shares . . . . . . . . . . . . . . . . . . . . . . . . . . . | . | 4 | |
4. | Proposed Granting of General Mandate to Issue Shares . . . . . . . . . . . . . . | 5 | |
5. | Annual General Meeting, Closure of Register of Members and Proxy Arrangement . . | . | 5 |
6. | Responsibility Statement . . . . . . . . . . . . . . . . . . . . . . . . . . | 6 | |
7. | Recommendation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . | 6 | |
Appendix I - Details of the Directors Proposed to be Elected and | |||
Re-elected at the Annual General Meeting . . . . . . . . . . . . . . | . | 7-14 | |
Appendix II - Explanatory Statement on the Share Repurchase | |||
Mandate . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . | . | 15-17 | |
Notice of Annual General Meeting . . . . . . . . . . . . . . . . . . . . . . . . . | . 18-22 |
- i -
DEFINITIONS
In this circular, unless the context otherwise requires, the following expressions shall have the following meanings:
"Annual General Meeting" | the annual general meeting of the Company to be held at 22/F, Central |
Plaza, 381 Middle Huaihai Road, Shanghai, PRC on Wednesday, June | |
16, 2021 at 3:00 p.m., to consider and, if appropriate, to approve the | |
resolutions contained in the notice of the meeting which is set out on | |
pages 18 to 22 of this circular, or any adjournment thereof | |
"Articles of Association" | the articles of association of the Company currently in force |
"Board" | the board of Directors |
"China" or "PRC" | the People's Republic of China (for the purpose of this circular, |
excluding Hong Kong, the Macau Special Administrative Region of the | |
PRC and Taiwan) | |
"Company" | SciClone Pharmaceuticals (Holdings) Limited, a company incorporated |
in the Cayman Islands with limited liability, the Shares of which are | |
listed on the Main Board of the Stock Exchange | |
"Director(s)" | the director(s) of the Company |
"Group" | the Company and its subsidiaries |
"HK$" | Hong Kong dollars, the lawful currency of Hong Kong |
"Hong Kong" | the Hong Kong Special Administrative Region of the People's Republic |
of China | |
"Issuance Mandate" | a general mandate proposed to be granted to the Directors to allot, issue |
or deal with additional Shares of not exceeding 20% of the total number | |
of issued shares of the Company as at the date of passing of the proposed | |
ordinary resolution contained in item 5 of the notice of the Annual | |
General Meeting | |
"Latest Practicable Date" | May 7, 2021, being the latest practicable date prior to the printing of this |
circular for ascertaining certain information in this circular | |
"Listing Date" | March 3, 2021, being the date on which the Shares first becoming listed |
on the Main Board of the Stock Exchange | |
"Listing Rules" | the Rules Governing the Listing of Securities on the Stock Exchange as |
amended from time to time | |
"Nomination Committee" | the nomination committee of the Company |
"RMB" | Renminbi, the lawful currency of the PRC |
"SFO" | the Securities and Futures Ordinance (Chapter 571 of the Laws of |
Hong Kong) |
- 1 -
DEFINITIONS
"Share(s)" | ordinary share(s) of US$0.00005 each in the issued capital of the |
Company or if there has been a subsequent sub-division, consolidation, | |
reclassification or reconstruction of the share capital of the Company, | |
shares forming part of the ordinary equity share capital of the Company | |
"Share Repurchase Mandate" | a general mandate proposed to be granted to the Directors to repurchase |
Shares on the Stock Exchange of not exceeding 10% of the total number | |
of issued shares of the Company as at the date of passing of the proposed | |
ordinary resolution contained in item 4 of the notice of the Annual | |
General Meeting | |
"Shareholder(s)" | holder(s) of Share(s) |
"Stock Exchange" | The Stock Exchange of Hong Kong Limited |
"Takeovers Code" | The Code on Takeovers and Mergers approved by the Securities and |
Futures Commission as amended from time to time |
- 2 -
LETTER FROM THE BOARD
SciClone Pharmaceuticals (Holdings) Limited
賽生藥業控股有限公司 *
(Incorporated in the Cayman Islands with limited liability)
(Stock code: 6600)
Executive Director: | Registered Office: |
Mr. Zhao Hong (Chief Executive Officer) | P.O. Box 309, Ugland House |
Grand Cayman, KY1-1104 | |
Non-executive Directors: | Cayman Islands |
Mr. Li Zhenfu (Chairman) | |
Dr. Daniel Luzius Vasella | Principal Place of Business in Hong Kong: |
Ms. Lin Shirley Yi-Hsien | 3401A, Windsor House |
Ms. Li Quan | 311 Gloucester Road |
Mr. Shi Cen | Causeway Bay |
Ms. Wang Xiaozhuo | Hong Kong |
Independent Non-executive Directors: | |
Dr. Liu Guoen | |
Dr. Chen Ping | |
Mr. Gu Alex Yushao | |
Ms. Wendy Hayes | |
May 14, 2021 | |
To the Shareholders | |
Dear Sir/Madam, |
PROPOSED ELECTION AND RE-ELECTION OF DIRECTORS
AND
PROPOSED GRANTING OF GENERAL MANDATES TO
REPURCHASE SHARES AND TO ISSUE SHARES
AND
NOTICE OF ANNUAL GENERAL MEETING
1. INTRODUCTION
The purpose of this circular is to provide the Shareholders with information in respect of certain resolutions to be proposed at the Annual General Meeting to be held on Wednesday, June 16, 2021.
* For identification purpose only
- 3 -
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
- Original document
- Permalink
Disclaimer
SciClone Pharmaceuticals (Holdings) Ltd. published this content on 13 May 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 13 May 2021 14:21:02 UTC.